Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.

作者: SHOHEI MIYANAGA , ITASU NINOMIYA , TOMOYA TSUKADA , KOICHI OKAMOTO , SHINICHI HARADA

DOI: 10.3892/IJO.2015.3291

关键词:

摘要: Taxanes, paclitaxel and docetaxel (DTX) are anticancer agents that exhibit cytotoxicity by inhibiting microtubule polymerization. They enhance the radiosensitivity of various cancers blocking cell cycle in most radiosensitive G2/M phase. Recently, taxanes have been reported to different mechanisms action depending on dose intensity. However, mechanism radio-enhancing effect DTX relation drug intensity is not clearly understood. In present study, we experimentally investigated effects concentrations against esophageal squamous cancer (ESCC); KES cells were used for vitro confirmation effective administration schedule chemoradiotherapy involving ESCC. enhanced radiation killing a concentration-dependent manner cells. High cytotoxic (>10 nM) strongly radiosensitivity. Low (<1 did showed inducing DNA double strand breaks apoptosis after irradiation. high induced G0/G1 phase arrest, respectively Cells treated with exhibited nuclear aggregation associated apoptotic change. contrast, low displayed multi-nucleation or unequal division. conclusion, enhancement ESCC was demonstrated, even using nanomolar effect. has its concentration. Therefore, weekly might effectively treatment

参考文章(47)
R Bruno, G J Sanderink, Pharmacokinetics and metabolism of Taxotere (docetaxel). Cancer surveys. ,vol. 17, pp. 305- 313 ,(1993)
Amanda J. McIlwrath, Robert Brown, Paul A. Vasey, Gillian M. Ross, Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Research. ,vol. 54, pp. 3718- 3722 ,(1994)
John T. Chaffey, Samuel Hellman, Differing Responses to Radiation of Murine Bone Marrow Stem Cells in Relation to the Cell Cycle Cancer Research. ,vol. 31, pp. 1613- 1615 ,(1971)
Gwenaelle Gravis, Franck Bladou, Naji Salem, Genevi�ve Macquart-Moulin, G�rard Serment, Jacques Camerlo, Dominique Genre, Val�rie-Jeanne Bardou, Dominique Maraninchi, Patrice Viens, Weekly administration of docetaxel for symptomatic metastatic hormone-refractory prostate carcinoma. Cancer. ,vol. 98, pp. 1627- 1634 ,(2003) , 10.1002/CNCR.11687
Katherine K. Sanford, Raymond Gantt, Gary M. Jones, Ram Parshad, Chromosomal radiosensitivity of human tumor cells during the G2 cell cycle period. Cancer Research. ,vol. 44, pp. 5577- 5582 ,(1984)
T. Kushida, S. Nohara, K. Yoshino, D. Fujiwara, K. Ouchi, T. Amano, F. Isayama, N. Tomita, Y. Iwanuma, K. Sasai, M. Tsurumaru, Y. Kajiyama, Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis. Diseases of The Esophagus. ,vol. 27, pp. 368- 373 ,(2014) , 10.1111/DOTE.12105
Keila Enitt Torres, Susan Band Horwitz, Mechanisms of taxol-induced cell death are concentration dependent Cancer Research. ,vol. 58, pp. 3620- 3626 ,(1998)
Luka Milas, Nancy R. Hunter, Kathryn A. Mason, Yoshihiro Saito, Lester J. Peters, Christopher G. Milross, Role of Reoxygenation in Induction of Enhancement of Tumor Radioresponse by Paclitaxel Cancer Research. ,vol. 55, pp. 3564- 3568 ,(1995)
Vincent Favaudon, Christophe Hennequin, Nicole Giocanti, Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Research. ,vol. 56, pp. 1842- 1850 ,(1996)
Héctor Hernández-Vargas, José Palacios, Gema Moreno-Bueno, None, Telling Cells How to Die: Docetaxel Therapy in Cancer Cell Lines Cell Cycle. ,vol. 6, pp. 780- 783 ,(2007) , 10.4161/CC.6.7.4050